CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 444 enrolled
Drug / intervention
FAM ACT +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03812614
NCT03812614N/ACompleted

Comparative Effectiveness of Adding Family Supporter Training to a CHW-Led Intervention to Improve Behavioral Management of Multiple Risk Factors for Diabetes Complications

University of Pittsburgh·interventional·Posted Jan 23, 2019·Updated Feb 13, 2025

In Brief

A clinical study evaluating FAM ACT and I-DSMES for Diabetes Mellitus and 3 related conditions. Completed, enrolled 444 participants across 2 sites.

Detailed Summary

The objective of this study is to compare the effectiveness of a novel program-Family Support for Health Action (FAM-ACT) - to individual patient-focused diabetes self-management education and support (I-DSMES).

Study Details

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJan 23, 2019
Enrollment StartSep 23, 2019
Primary CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 7.4 years ago

Interventions

FAM ACTbehavioral

Patient and Support Person (dyad) will receive a Diabetes Complications Risk Assessment profile and introduction session, Support Person-focused information/skills training through 4-6 extended DSME sessions, case management contacts with CHW throughout the duration of the 6-month intervention, and guidance on how to prepare for and participate in healthcare appointments.

I-DSMESbehavioral

Patient only will receive a Diabetes Complications Risk Assessment profile and introduction session, 4-6 group DSME sessions, case management contacts with CHW throughout the duration of the 6-month intervention, and guidance on how to prepare for and participate in healthcare appointments.